Committed to delivering future-proof, non-invasive delivery technologies.
Investing in your future from scale-up to commercialisation and market launch.
Your requirements are in safe hands.
Transdermal therapeutic systems that actively improve outcomes for all.
Oral thin film technologies – the ideal dose for fast delivery.
Micro Array Patches – The game changer microneedle technology.
Realising value for partners and better outcomes for patients.
Meet the people behind the technology.
Incisive thought leadership on non-invasive drug delivery.
Our expertise brought to life.
Touching every part of the skin.
Keep to up to date with LTS around the world.
Where we can meet up.
Since 1984 we have been focused on utilizing our expertise, experience and innovation to create market leading drug delivery solutions for our pharmaceutical partners.
patent families owned
The manufacturer’s authorisation for LTS is extended to the manufacturing of capsules.
LTS manufactures the first OTF for the treatment of breakthrough pain in chronic cancer pain.
Launch of an ondansetrone OTF for the treatment and prophylaxis of acute nausea and vomiting induced by moderately emetogenic chemotherapy.
Launch of the first ibuprofen patch, a local analgesic for the treatment of articular painful conditions, both traumatic and rheumatic.
Launch of the first transdermal patch for the treatment of Alzheimer’s disease
Launch of the first transdermal patch for the treatment of Parkinson’s disease
The first nicotine patch for smoking cessation is launched in the US
The first TTS matrix system from LTS achieves approval and is launched, a nitroglycerin patch.
With teams of experts on hand across the globe, we are here to support your next innovative drug delivery development programme.
+49 2632 990
+1 973 575 5170
+86 21 5081 2266 ext. 1832